Results 161 to 170 of about 5,262,931 (244)

Repertoire selection and effector differentiation during NKT cell development

, 2012
Natural killer T (NKT) cells are innate-like lymphocytes that develop and mature in the thymus. From there, they home to the peripheral lymphoid tissues where, in some cases, they can finalise the maturation program. NKT cells function by close cell-cell
Gordy, Laura Elizabeth
core  

Ovarian cancer-associated immune exhaustion involves SPP1+ T cell and NKT cell, symbolizing more malignant progression. [PDF]

Front Endocrinol (Lausanne), 2023
Wang K, Hou H, Zhang Y, Ao M, Luo H, Li B.   +5 more
europepmc   +1 more source

The NKT cell TCR repertoire can accommodate structural modifications to the lipid and orientation of the terminal carbohydrate of iGb3. [PDF]

RSC Adv, 2022
Cameron G, Cheng JMH, Godfrey DI, Timmer MSM, Stocker BL, Dangerfield EM.   +5 more
europepmc   +1 more source

All-Hydrocarbon Macrocycle Enables Highly Potent Th1-Biased NKT Cell Agonists for Immunotherapy. [PDF]

JACS Au
Sun QN, Wen Y, Wu YH, Mei DX, Liu ZQ, An XY, Guo J.   +6 more
europepmc   +1 more source

Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients. [PDF]

Cancers (Basel), 2022
Flores-Gonzalez J, Ramon-Luing LA, Ocaña-Guzman R, Buendia-Roldan I, Islas-Muñoz B, Volkow-Fernández P, Chavez-Galan L.   +6 more
europepmc   +1 more source

Parity-induced changes to mammary epithelial cells control NKT cell expansion and mammary oncogenesis. [PDF]

Cell Rep, 2021
Hanasoge Somasundara AV, Moss MA, Feigman MJ, Chen C, Cyrill SL, Ciccone MF, Trousdell MC, Vollbrecht M, Li S, Kendall J, Beyaz S, Wilkinson JE, Dos Santos CO.   +12 more
europepmc   +1 more source

Dietary sulfur amino acids enhance anti-tumor immunity in colon cancer via an NKT cell-XCL1-cDC1 circuit. [PDF]

Immunity
Lobel L, Fonseca-Pereira D, Nakatsu G, Michaud M, Cao YG, Bae S, Krabak C, Oren Y, Clay SL, El Tekle G, Chun E, Kon S, Chan AT, Clardy J, Glickman JN, Ajami NJ, Day A, Damania A, Baruch EN, White MG, Diggs LP, Wargo J, Riffelmacher T, Balancio A, Kronenberg M, Huttenhower C, Garrett WS.   +26 more
europepmc   +1 more source

Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model. [PDF]

Cancer Immunol Immunother, 2022
Varghese B, Lynch L, Vriend LE, Draganov D, Clark JM, Kissick HT, Varghese S, Sanda MG, Dranoff G, Arredouani MS, Balk SP, Exley MA.   +11 more
europepmc   +1 more source

Highly Potent Th1-Type NKT Cell Agonists as Immunotherapeutic Agents via Conformational Restriction Design. [PDF]

JACS Au
Wen Y, Wu YH, Sun QN, Wang EY, Luo MQ, Fu ZR, Zhou Z, Mei DX, Guo J.   +8 more
europepmc   +1 more source

Distinct B and NKT cell responses shape the delayed response to ChAdOx1 nCoV-19 vaccine in end-stage renal disease. [PDF]

J Infect, 2022
Putri DU, Lin CF, Hung CS, Huang CK, Ou TY, Lai CY, Tseng PC, Cheng CY, Lee CH.   +8 more
europepmc   +1 more source